+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 4
Age: 18Years +
All Genders
ID06401616

Randomized Trial Evaluating Anticoagulant Therapy in Atrial Fibrillation Patients After Surgical Left Atrial Appendage Closure

Led by Odense University Hospital · Updated on 2026-10-21

1220

Participants Needed

6

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are studying patients with atrial fibrillation who have had surgical closure of the left atrial appendage LAA to see if they can safely stop taking oral anticoagulants. This trial addresses the important question of whether anticoagulant therapy is still needed after successful LAA closure, since continuing anticoagulation carries a risk of bleeding. The study is a randomized trial enrolling 1220 patients to evaluate risks of stroke, embolism, and bleeding. Participants will first undergo a cardiac CT scan to confirm the success of their LAA closure. Those with successful closure will be randomly assigned to either stop or continue their oral anticoagulant medications, which include warfarin, dabigatran, rivaroxaban, apixaban, or edoxaban. The trial compares these two groups over approximately four years to assess key health outcomes. During the study, participants will be monitored for ischemic strokes, peripheral arterial embolisms, and major bleeding events. Additional evaluations include the severity of strokes, transient ischemic attacks, mortality rates, minor bleeding, and quality of life assessments at baseline, one year, and two years. The trial aims to provide detailed safety and effectiveness data about continuing versus stopping anticoagulants after surgical LAA closure.

CONDITIONS

Brief Title

Can Patients With Atrial Fibrillation Safely Discontinue Anticoagulant Therapy After Cardiac Surgery? (ATLAAC)

Research Team

K

Kristina Gosvig, M.D.

J

Julie Goller, M.D.

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here